Evidence map›Paper›PMID 33058469›Full record

ArticleBJU international2021

Morbidity and mortality after robot-assisted radical cystectomy with intracorporeal urinary diversion in octogenarians: results from the European Association of Urology Robotic Urology Section Scientific Working Group.

Ashkan Mortezavi, Alessio Crippa, Sebastian Edeling, Sasa Pokupic, Paolo Dell'Oglio, Francesco Montorsi, Frederiek D'Hondt, Alexandre Mottrie, Karel Decaestecker, Carl J Wijburg and 10 more

Open access · hybridAbstract read
In one paragraph

Article in BJU international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. [Urinary diversion in old patients (80+ years)].Urologie (Heidelberg, Germany) · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 9 countries.

Ashkan MortezaviDepartment of Molecular Medicine and Surgery, Section of Urology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-6307-2659
Alessio CrippaDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-2254-2420
Sebastian EdelingDepartment of Urology, Vinzenzkrankenhaus Hannover, Hannover, Germany.
Sasa PokupicDepartment of Urology, Vinzenzkrankenhaus Hannover, Hannover, Germany.ORCID 0000-0002-4392-6554
Paolo Dell'OglioUnit of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.ORCID 0000-0002-2771-2919
Francesco MontorsiUnit of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
Frederiek D'HondtDepartment of Urology, Onze Lieve Vrouw Hospital, Aalst, Belgium.
Alexandre MottrieDepartment of Urology, Onze Lieve Vrouw Hospital, Aalst, Belgium.ORCID 0000-0002-1253-1592
Karel DecaesteckerDepartment of Urology, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0003-0767-940X
Carl J WijburgDepartment of Urology, Rijnstate Hospital, Arnhem, the Netherlands.ORCID 0000-0002-0627-5377
Justin CollinsDepartment of Urology, University College London Hospital, London, UK.
John D KellyDepartment of Urology, University College London Hospital, London, UK.
Wei Shen TanDepartment of Urology, University College London Hospital, London, UK.ORCID 0000-0002-6119-4043
Ashwin SridharDepartment of Urology, University College London Hospital, London, UK.
Hubert JohnDepartment of Urology, Kantonsspital Winterthur, Winterthur, Switzerland.
Abdullah Erdem CandaDepartment of Urology, School of Medicine, Koç University, Istanbul, Turkey.ORCID 0000-0002-5196-653X
Christian SchwentnerDepartment of Urology, Diakonie Klinikum Stuttgart, Stuttgart, Germany.
Erik Peder RönmarkDepartment of Molecular Medicine and Surgery, Section of Urology, Karolinska Institutet, Stockholm, Sweden.
Peter WiklundDepartment of Molecular Medicine and Surgery, Section of Urology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-6497-4697
Abolfazl HosseiniDepartment of Molecular Medicine and Surgery, Section of Urology, Karolinska Institutet, Stockholm, Sweden.
Karolinska Institutet · SEUniversity College Hospital · GBOnze Lieve Vrouwziekenhuis Hospital · BEVinzenzkrankenhaus Hannover · DEDiakonie-Klinikum Stuttgart · DEGhent University Hospital · BEIRCCS Ospedale San Raffaele · ITKantonsspital Winterthur · CHKoç University · TRRijnstate Hospital · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate the postoperative complication and mortality rate following laparoscopic radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD) in octogenarians. PATIENTS AND

methodsWe conducted a retrospective analysis comparing postoperative complication and mortality rates depending on age in a consecutive series of 1890 patients who underwent RARC with ICUD for bladder cancer between 2004 and 2018 in 10 European centres. Outcomes of patients aged <80 years and those aged ≥80 years were compared with regard to postoperative complications (Clavien-Dindo grading) and mortality rate. Cancer-specific mortality (CSM) and other-cause mortality (OCM) after surgery were calculated using the non-parametric Aalen-Johansen estimator.

resultsA total of 1726 patients aged <80 years and 164 aged ≥80 years were included in the analysis. The 30- and 90-day rate for high-grade (Clavien-Dindo grades III-V) complications were 15% and 21% for patients aged <80 years compared to 11% and 13% for patients aged ≥80 years (P = 0.2 and P = 0.03), respectively. In a multivariable logistic regression analysis adjusting for pre- and postoperative variables, age ≥80 years was not an independent predictor of high-grade complications (odds ratio 0.6, 95% confidence interval 0.3-1.1; P = 0.12). The non-cancer-related 90-day mortality was 2.3% for patients aged ≥80 years and 1.8% for those aged <80 years, respectively (P = 0.7). The estimated 12-month CSM and OCM rates for those aged <80 years were 8% and 3%, and for those aged ≥80 years, 15% and 8%, respectively (P = 0.009 and P < 0.001).

conclusionsThe minimally invasive approach to RARC with ICUD for bladder cancer in well-selected elderly patients (aged ≥80 years) achieved a tolerable high-grade complication rate; the 90-day postoperative mortality rate was driven by cancer progression and the non-cancer-related rate was equivalent to that of patients aged <80 years. However, an increased OCM rate in this elderly group after the first year should be taken into account. These results will support clinicians and patients when balancing cancer-related vs treatment-related risks and benefits.

Indexed as

AgedAged, 80 and overAge FactorsCystectomyEuropeFemaleHumansLymph Node ExcisionMaleMiddle AgedOperative TimePostoperative ComplicationsProportional Hazards ModelsRetrospective StudiesRisk FactorsRobotic Surgical Proceduresbladder cancer#BladderCancer#blcsmcomplication#EndoUrologyintracorporeal diversionmortalityoctogenarianrobot-assisted radical cystectomy#uroonc

Identifiers

PMID33058469
PMCPMC8246851
OpenAlexW3093471841

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.